<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3APriced_round</id>
	<title>Definition:Priced round - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3APriced_round"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Priced_round&amp;action=history"/>
	<updated>2026-06-14T05:54:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Priced_round&amp;diff=17031&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Priced_round&amp;diff=17031&amp;oldid=prev"/>
		<updated>2026-03-15T10:01:33Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;💰 &amp;#039;&amp;#039;&amp;#039;Priced round&amp;#039;&amp;#039;&amp;#039; is a type of equity financing event in which an [[Definition:Insurtech | insurtech]] startup or other insurance-sector venture issues shares at a specific, agreed-upon [[Definition:Valuation | valuation]], establishing a definitive price per share. Unlike convertible instruments such as [[Definition:Convertible note | convertible notes]] or [[Definition:Simple agreement for future equity (SAFE) | SAFEs]] — which defer the valuation question to a later date — a priced round requires the company and its investors to negotiate and settle on how much the business is worth at that moment. In the insurance and insurtech ecosystem, priced rounds typically become relevant once a company has moved beyond its earliest seed stage and is raising [[Definition:Series A funding | Series A]] or later capital from [[Definition:Venture capital (VC) | venture capital]] firms, [[Definition:Corporate venture capital (CVC) | corporate venture arms]] of insurers, or [[Definition:Private equity (PE) | private equity]] investors.&lt;br /&gt;
&lt;br /&gt;
📄 The mechanics involve issuing a new class of preferred stock — most commonly Series A, B, or C preferred shares — with rights, preferences, and protections spelled out in a detailed term sheet and subsequent legal documentation. The [[Definition:Pre-money valuation | pre-money valuation]] is the company&amp;#039;s assessed worth before the new capital is injected; adding the investment amount yields the [[Definition:Post-money valuation | post-money valuation]]. Investors in a priced round typically receive [[Definition:Liquidation preference | liquidation preferences]], [[Definition:Anti-dilution provision | anti-dilution protections]], board representation, and information rights. For insurtech companies, these rounds frequently involve strategic investors — such as the venture arms of [[Definition:Reinsurer | reinsurers]] like [[Definition:Munich Re | Munich Re]] or [[Definition:Swiss Re | Swiss Re]], or innovation funds affiliated with major [[Definition:Insurance carrier | carriers]] — who bring not only capital but also distribution partnerships, regulatory insight, and underwriting capacity. The due diligence process for a priced round in insurance-focused ventures often scrutinizes the company&amp;#039;s [[Definition:Loss ratio (L/R) | loss ratio]] trajectory, regulatory licensing status, and the durability of its [[Definition:Managing general agent (MGA) | MGA]] or [[Definition:Broker | brokerage]] relationships.&lt;br /&gt;
&lt;br /&gt;
🔍 The significance of a priced round extends well beyond the capital itself. It creates a formal, third-party-validated benchmark of a company&amp;#039;s worth — a reference point that influences employee [[Definition:Stock option | stock option]] values, future fundraising leverage, and the company&amp;#039;s credibility with insurance partners who need assurance that a technology vendor will remain solvent and operational. In the insurtech sector, where startups must often secure [[Definition:Binding authority agreement | binding authority agreements]] or regulatory approvals that hinge on financial stability, a well-structured priced round can be the difference between gaining carrier trust and being sidelined. The transition from convertible instruments to a priced round also marks a governance inflection point: the company gains a formal board with investor representation, more rigorous financial reporting obligations, and heightened accountability — all of which mirror the culture of compliance that permeates the insurance industry the startup aims to serve.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Series A funding]]&lt;br /&gt;
* [[Definition:Valuation]]&lt;br /&gt;
* [[Definition:Venture capital (VC)]]&lt;br /&gt;
* [[Definition:Convertible note]]&lt;br /&gt;
* [[Definition:Simple agreement for future equity (SAFE)]]&lt;br /&gt;
* [[Definition:Pre-money valuation]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>